Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05410002 · ClinicalTrials.gov registry record · Phase 1
Diet Effect on Cancer Treatment Outcome
A Phase 1 study, sponsored by Optimal Health Research.
- Completed
- Registry status
- Phase 1
- Development phase
- 160
- Enrollment target
NCT05410002 is a Phase 1 study that has completed, run by Optimal Health Research. The registered enrollment target is 160 participants.
The verdict
NCT05410002, a Phase 1 study, has completed, sponsored by Optimal Health Research.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 160 participants
- Enrollment target
Study Summary
The study will look at the end result of 2 types of diets effect on treatment outcome of cancer patients using N-111.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Dietary Supplement: N-111
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2022-10-12 |
| Est. Completion | 2024-10-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05410002
The ClinicalTrials.gov registry entry for NCT05410002 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Optimal Health Research, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05410002 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05410002 about?
NCT05410002 is a clinical study titled "Diet Effect on Cancer Treatment Outcome". The study will look at the end result of 2 types of diets effect on treatment outcome of cancer patients using N-111.
What is the current status of trial NCT05410002?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 160 participants. The study started on 2022-10-12. Estimated completion is 2024-10-01.
What interventions are being tested in trial NCT05410002?
The interventions under investigation include: Placebo (OTHER), Dietary Supplement: N-111 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05410002?
This trial is sponsored by Optimal Health Research, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.